The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Tuesday 14, June 2022. The committee will meet in open session to discuss an Emergency Use Authorization (EUA) request made by Moderna for a COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age.